Grants and Contributions:
Title:
Enterprise Digital Therapeutic Platform for Digestive Diseases & Disorders
Agreement Number:
907222
Agreement Value:
$45,088.00
Agreement Date:
May 15, 2018 - Feb 15, 2019
Description:
To develop an enterprise platform to support both B2C and B2B business models in commercializing therapeutic programs for digestive health.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Delta, British Columbia, CA V4E 3L8
Reference Number:
172-2018-2019-Q1-907222
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
842794810
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 15 days.
Amendment Date
Jan 9, 2019
Recipient's Legal Name:
KORE Digital Health Therapeutics Inc.
Federal Riding Name:
Delta
Federal Riding Number:
59011
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541514
Amendments: